Walgreens reports a $5.8 billion charge due to clinic operator VillageMD

Wal­greens is cut­ting down on a part of its busi­ness it once saw as a key part of its fu­ture.

The health gi­ant re­port­ed a net loss of $5.9 bil­lion dur­ing quar­ter­ly earn­ings Thurs­day, with $5.8 bil­lion of it be­ing an im­pair­ment charge on its in­vest­ment in its pri­ma­ry care chain Vil­lageMD.

It al­so plans to close 160 clin­ics to­tal, ex­ec­u­tives said on the earn­ings call, a leap from the 60 un­der­per­form­ing clin­ics the com­pa­ny planned to shut­ter last fall as part of its cost-cut­ting goal of $1 bil­lion. The re­tail­er has since closed all stores in states such as Illi­nois and Flori­da.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Bristol Myers drops another CytomX program

Bris­tol My­ers Squibb dropped an­oth­er CT­LA-4 pro­gram from its decade-long re­search col­lab­o­ra­tion with Cy­tomX af­ter the big phar­ma re­viewed its port­fo­lio. Cy­tomX an­nounced the change

Read More »